Elon Musk’s Neuralink has been given the green light to implant its brain chip in a second patient after fixing problems that arose during the first human trial.
The U.S. Food and Drug Administration (FDA) on Monday approved the next person and signed off on the company’s planned updates, which include embedding some of the device’s ultra-thin wires more deeply into the brain.
Neuralink revealed this month that some of the 64 wires came loose from the first patient’s brain, causing the chip to malfunction, almost ending the trial that started in January.
A Reuters report quoted “five people familiar with the matter” as saying the issue “has been known for years” through animal testing.
This is a developing story…more updates to come.
Elon Musk’s Neuralink has been given the green light to implant its brain chip in a second patient after resolving issues that arose during the first human trial
In January, Neuralink implanted a brain chip in its first patient, Noland Arbaugh, who is paralyzed from the shoulders down following a 2016 diving accident
Nolan Arbaugh was the first to receive the brain chip after a life-altering driving accident while working as a camp counselor in 2016 left him with “absolutely no feeling” from his shoulders down.
